Recurrent MGMT-Methylated Glioblastoma
1 clinical trials · Condition
◉ Watch Recurrent MGMT-Methylated Glioblastoma
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment (NCT05432804) | National Cancer Institute (NCI) | 2023-03-20 |
Track Recurrent MGMT-Methylated Glioblastoma automatically
Every clearance here is in the API, with alerts when new ones post.